Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"All financial terms of the agreement with Amgen is subject to a CTO. Read the filings. You don’t obtain a CTO if the agreement doesn’t require confidentiality" .... Prove that the terms of the CTO includes prohibiting ADXS from disclosing this vital information of milestone payments in a press release to the market. Prove that ADXS agreed to be gagged by Amgen to only disclose milestone payments in a quarterly report. You have failed to post the filings where it clearly states that ADXS is prohibited from disclosing milestone payments from Amgen.
"You continue to ignore the fact that any milestone payment will first be disclosed in the quarterly report for the quarter in which it is received." ......If any milestone payments were made, you are stating that Berlin would not disclose this vital news in a press release, especially since everyone knows that ADXS is in dire need of cash. You state that Berlin would sit on this vital news & not disclose the payments until the next quarterly report. Incredibly naïve statement. If Berlin did that he should be immediately terminated & all his options cancelled.
"That’s a nice plot for a novel. Any evidence that Ken is sitting on a deal or other good news until after warrants expiration? I didn’t think so." .....You finally posted something correct about con man Ken Berlin. He is not sitting on ANY deal for AXAL, HOT or a buy out. Berlin has no regard or respect for ADXS warrant holders as he will let the warrants expire worthless when he could extend the expiration for at least two years.
"Thanks again Marc for your daily diagnosis.
LOL" ..Your welcome girlfriend. OUT OF MY WAY...I NEED A LATTE. LOL.
"So true, I just sold everything based on your ever so concerned position....lol " ...You finally see the truth, what a miracle. It's about time. LOL
The first NEO patient was dosed two months ago. Since there have been NO milestone payments to ADXS from Amgen, there are zero milestone payments for the first dosed NEO patient. ADXS shareholders are not allowed to know what, IF ANY, milestone payments ADXS is entitled to from Amgen for NEO. Very disrespectful, disappointing & annoying for all ADXS share & warrant holders.
Con man Ken Berlin, displaying his total disrespect & disregard for warrant holders, is going to let the warrants expire worthless, totally screwing the warrant holders who believed ADXS was the real deal.
"While Axal has substantial commercial value it pales in comparison to neo or hot." ... What a bunch of nonsense. If AXAL & HOT had substantial commercial value, Berlin would have closed big upfront AXAL & HOT cash deal partnerships by now. No excuses for Berlin's failures if that absurd statement is true. The fact is, neither AXAL or HOT have proved to have ANY commercial value at all. Post the proof for this absurd statement.
"I would say it’s because of our greedy BOD. Who have no negotiating skills what so ever. I don’t think it’s the science but could be wrong" ......... It's not the greedy BOD's job to negotiate deals. It's con man Ken Berlin's responsibility to negotiate deals. It appears that Berlin lacks the necessary skills to find & close the deal.
"Instead it looks like no one is interested in ADXS products other than AMGN and NEO.
IF so, sell the beech to AMGN now." .....If Amgen wanted to buy ADXS they could do it today for less than peanuts & get AXAL & HOT along with NEO, the entire ADXS LM platform. So why has AMGEN not bought out ADXS? Seems like a no brainer to me.
"Marc do they have our LM Platform? I don’t think so! That’s a HUGE difference my friend!" ...No, ADRO has their own LM Platform. That's a HUGE difference my friend!
"20 other companies ahead of ADXS with NEO, do they all get bought
out before ADXS?" .... Chances are NONE of the other companies will get bought out until Neoantigen vaccines prove they are the real deal & obtain FDA approval.
No wonder con man Ken Berlin can't find a upfront big cash partner for the overhyped, totally unproved HOT. There are many other companies that are way ahead of ADXS HOT in Neoantigen therapy development. ADRO is in phase 1 with their listeria platform. Many others are in phase 2 & 3. Many are pre clinical like HOT. Why would any BP want to partner with a company like ADXS for HOT when HOT is just one of many pre clinical options for BP to choose from which are all way behind the other companies that are already in phase 1,2 & 3?
"But in reality, especially in the corporate world, Ken will look like a bigger bozo if he walks away from all the perks and salary that come with the job that has no claw back clause." ...If Berlin doesn't resign then he should be fired immediately. ADXS has had more than enough incompetent bozo CEOs.
The only reason for not closing a big cash upfront partnership for AXAL is the incompetence & lack of skills of con man Ken Berlin. This is what ADXS says about AXAL:
CERVICAL CANCER: PHASE 3 AIM2CERV STUDY
AXAL has shown promising anti-tumor activity and acceptable tolerability across several clinical trials. Advaxis has reached an agreement on a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) in June 2016 for the Phase 3 AIM2CERV study, evaluating the safety and efficacy of AXAL administered in the adjuvant setting after completion of cisplatin-based chemotherapy and radiotherapy in patients with locally advanced cervical cancer at higher risk for recurrence, progression, or death. The study plans to enroll approximately 450 patients, and is on track with enrollment. The Phase 3 trial will be conducted in collaboration with the GOG Foundation, Inc, now part of NRG Oncology. AXAL also received Fast Track Designation from the FDA as an adjuvant therapy for HRLACC patients and was classified as an advanced-therapy medicinal product by the European Medicines Agency’s Committee for Advanced Therapies for the treatment of cervical cancer.............BP should be knocking Berlin's door down to get a piece of AXAL. AXAL is now in phase 3 trial. In less than two years AXAL will either prove to be the real deal & be worth multi millions once in production or it will prove to be a dud. Most of the cost to prove up AXAL has already been paid for by ADXS shareholders. Potential BIG time return with limited financial risk for any BP. This should be an easy slam dunk for con man Ken Berlin. If Berlin cant get a upfront big cash partner for AXAL NOW, he should immediately resign & give back any options granted to him as he will have proved to be just another incompetent ADXS bozo CEO.
More pain, disappointment & lost money in the cards for all ADXS share & warrant holders, dreamers & bag holders. Con man Ken Berlin can't find an upfront big cash partner for AXAL & the overhyped, totally unproved HOT. AXAL, NEO & HOT are all based on the unproved LM technology. AXAL was going to prove that the LM technology is the real deal. After over 6 years & millions of dollars of shareholder capital, AXAL, which is now in phase 3, is going to be shelved by Berlin leaving ADXS LM technology still totally unproved. I posted many times that AXAL is a dud & would not get FDA or EU approval. That is the reason that ADXS has collapsed in price, & why there are no big upfront cash partners for AXAL or HOT. Amgen took a flyer on NEO, but waited over two years to get the first patient dosed, wants no part of AXAL, HOT or buying out ADXS. Con man Ken Berlin is going to have raise money by mass diluting current shareholders just to keep the lights on. Berlin knows he can't dilute at the current share price as that would crash the stock under $1 & could cause ADXS to be delisted from NASDQ. Before Berlin starts diluting, he will institute ANOTHER big time REVERSE SPLIT, which will wipe out current shareholder equity. After the reverse split, the share price will collapse again because after over 6 years of FDA trials, ADXS LM Technology is still totally unproved. Con man Ken Berlin will prove to be just another incompetent ADXS CEO.
"Why would that be "absolute" proof that he is running a "con game?" ...If the market believed in Berlin's HOT & NEO hype, & that AXAL being shelved when it is in phase 3 is a good thing, the share price would not be trading at $1.41, down from the all time high around $30. ADXS shareholders, dreamers & bag holders believed Berlin's con game would move the share price much higher, but once again just another crushing disappointment as the market voted a big thumbs down on Berlin's con game.
"Please provide some evidence, a link will do, that the market believes Ken is a con man. Thanks in advance." ... The absolute proof that the market does not believe in Ken Berlin's con game is the ADXS share & warrant price.
If Ken can't get a strong deal for HOT then post the for sale sign." Problem is, Amgen doesn't want to buy ADXS even with AXAL & HOT thrown in for free with NEO. No other BP will buy ADXS when they know that Amgen, who knows more about ADXS than any BP, wants no part of buying ADXS. More con man Ken Berlin failures.
"I'm willing to bet dollars to donuts Ken has something lined up with HOT NSCLC". Hold on to your donuts as you are on the losing end of that ADXS bet.
The market believes that Berlin is a con man & the market was not duped by Berlin's HOT hype & his failure to find upfront big cash partners for AXAL & HOT. ADXS desperately needs big time cash to survive & Berlin lacks the managerial skills to find big up front cash partners for AXAL & HOT & close the deal.
More big time pain & loss of gambled ADXS money in the cards for ADXS shareholders & dreamers. When CEO con man Ken Berlin falls flat on his face & fails to find up front big cash partners for AXAL & the extremely over hyped, totally unproven HOT, Berlin will shelve AXAL & have to raise cash by mass diluting current ADXS shareholders to keep the company alive. Berlin knows he cant dilute at current prices as it would immediately crash the stock under $1 & ADXS would get delisted from NASDQ. Before con man Berlin can foist this mass dilution on current shareholders, Berlin will institute ANOTHER MONSTER REVERSE SPLIT in order to find legitimate big time funders. Beware of con man Ken Berlin's game as he will fail, just as the previous bozo ADXS CEOs all failed. Look out below, more pain coming to all ADXS shareholders, warrant holders, dreamers & bag holders.
The market has voted overwhelmingly thumbs down on con man Ken Berlin's HOT HYPE. Hot is based on ADXS LM technology which after six years of AXAL FDA trials & millions of dollars of shareholder capital is a totally unproved science. AXAL was going to prove the LM technology was the real deal & was the ADXS LEAD cancer vaccine. The big red flag that Berlin still can't find a cash partner for AXAL, which is now in phase three & is about two years from proving if it is the real deal or a dud. If there are no cash partners, Berlin will shelve AXAL & the LM technology will remain a totally unproved science. What BP is going to put up big time cash upfront for HOT when Berlin will shelve AXAL leaving the LM technology still just an unproved, over hyped speculative technology. This could also be the reason ADRO is getting hammered today trading at a new 52 week low.
"They are constantly negotiating partnerships and they don’t want to Telegraph the terms of their other deals. I fail to see how this fact reflects negatively on the Amgen deal." .. It has negatively affected the ADXS share price. If there are ANY milestone payments, disclosure of these cash payments should be very positive for the share price. ADXS is in dire need of cash & milestone payments would be an early validation that NEO could be the real deal & Amgen will continue the trials.
"Enrolled patients will undergo a biopsy etc" ... That does not in any way disclose what & when, IF ANY, are the milestone payments to ADXS from Amgen for NEO.
"The details of the Amgen deal are subject to an SEC CTO." ... Why would Amgen & ADXS agree have the details of the Amgen deal purposely gagged by the Sec CTO? This is certainly extremely important information & it is very negative for ADXS shareholders & detrimental to the market price of the stock NOT to know when & what, if any, are the milestone payments to ADXS from Amgen now that the first patient was dosed. ADXS is in dire need of funds & the share price has collapsed. ADXS should want this information fully disclosed & should not have agreed to have the SEC gag on the Amgen details. Amgen should also want the milestone payments disclosed as any payments to ADXS for NEO would validate that NEO will continue to advance in clinical trials.
What & when are the milestone payments from Amgen to ADXS for NEO as the first NEO patient was dosed on June 11? I posted this yesterday & not even the most ardent supporters of ADXS could answer this critically important Amgen-ADXS NEO question because nobody knows.
What & when are the milestone payments from Amgen to ADXS for NEO as the first NEO patient was dosed on June 11?
"At some point in time - People just need to realize that the stock is way undervalued." .. The market believes that ADXS is NOT undervalued. Only the share price speaks the truth.
"Everyone knows ADXS is high-risk. The salient point you’re omitting is that NEO may be enough, all by itself, to warrant a much higher valuation." ... It will be many, many years before NEO is either proved to be the real deal with FDA approval or another ADXS dud. ADXS share price has collapsed from $16 since Amgen partnered for NEO. More mass dilution & another reverse split coming next year. Berlin is another in the long list of previous ADXS incompetent CEO failures.
"Right. As opposed to when Amgen licensed NEO. It was totally proven at that point. LOL".. Neo is far from being proven. Post any NEO vaccine that has FDA approval & is on the market. LOL
"It can be but as you can see ADXS has already recovered from its all time low." ..ADXS has not recovered from it's all time Berlin low. Current price just a dead cat bounce off the all time lows. New lows coming soon.
"Close the deal KB."
Ken Berlin lacks the management skills to find & close deals. Just another incompetent bozo CEO for ADSX. More disappointment for ADXS dreamers.
"sorry my friend, HOT is very hot!Amgen might takes all!" ... Sorry my friend, no BP knows more about ADXS than Amgen. Amgen wants no part of the high risk, over hyped, totally unproven HOT or AXAL. Amgen is only interested in NEO.
"Yeah Yeah if you call a few pennies that relevant....LOL" ..A new ALL TIME LOW is always very relevant & very ominous for the future.
"But the share price was already near where it’s at BEFORE Berlin joined ADXS." ... ADXS made a new ALL TIME LOW after Berlin tried to con the market with his HOT hype & shelving AXAL.
"Thank you for your very extensive update. Always enjoy reading your messages." ... Thank you & glad you enjoy reading my posts. Congratulations are increasing your position & your big time losses in ADXS.
The market has voted a monster thumbs down on con man Ken Berlin. Berlin knew that he would have to find a way to cut costs so he didn't have to dilute as soon as this October. Mass dilution would have immediately collapsed the share price under $1 & ADXS could be kicked off the NASDQ which would force Berlin to again monster reverse split the stock to get back on NASDQ. To Berlin's credit he did cut the bloated work force by 24% to reduce bloated G&A costs. However, the real cost savings was to try to partner or shelve AXAL because Berlin could not afford to continue the AXAL phase 3 trials without immediate dilutive financing which would have collapsed the share under $1 etc. In order to justify the AXAL trials being shelved, Berlin tied to con the market into believing that HOT was the next greatest new thing in cancer vaccines. High risk, totally unproved Neo is financed by Amgen so Neo is not a cost factor to ADXS. HOT however is unproved, totally overhyped, extremely high risk & there is no way Berlin can finance HOT without an upfront big cash partner. Problem is Berlin, who lacks the skills to find & close deals, can't find an up front cash partner for AXAL, a phase 3 vaccine which if it gets FDA approval could be on the market within two years. The over hyped HOT has not yet started any trials & it would be many years before HOT is either proved to be the real deal or another ADXS dud. BP has a choice with ADXS. Either be a big cash partner for phase three AXAL or pay big time up front cash for totally over hyped, unproved high risk HOT. ADXS has NEVER found a cash partner for AXAL even though AXAL has made it to phase 3 & there is 99% chance that Berlin will NOT find a big up front cash partner for over hyped, totally unproved, very high risk HOT. BP has chosen NOT to partner with Berlin on either AXAL or HOT. The market did not fall for Berlin's con as the share price collapsed to new all time lows shortly after Berlin was made CEO. The ADXS dreamers, bag holders did get duped by Berlin, hook line & sinker. With no cash partners, Berlin will be forced to mass dilute & reverse split the stock again which will be another ADXS disaster for shareholders.
Berlin should easily & quickly be able find a cash partner for AXAL as opposed to finding an up front cash partner for the totally unproven, incredibly over hyped HOT. AXAL is in phase 3 trials & in less than two years AXAL could be FDA approved, assuming AXAL is the real deal. HOT is now nothing but HOT AIR, incredibly risky, & has not even started any FDA trials yet. Question is, why hasn't Berlin closed an upfront cash deal for AXAL yet? Either no BP believes that AXAL is the real deal or Berlin is incompetent & lacks the skills necessary find & close up front cash deals.
It is most bizarre that no entity has stepped up to the plate & either bought or cash partnered for AXAL. There is far less risk in AXAL at this point than trying to peddle HOT. AXAL is in phase 3, so it will be far faster to get to market, assuming AXAL is the real deal, than HOT which has yet to prove anything. Most of the financial cost for AXAL FDA approval have already been paid for & so far the trial results look promising. If AXAL is the real deal it will be worth multi millions. BP should be tripping all over each other for AXAL, yet Berlin still can't find an upfront cash partner or buyer for AXAL. Very Bizarre & disappointing.